ImmuCell Corporation
ICCC
$6.25
$0.1652.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -20.11% | 4.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.11% | 4.08% | |||
| Cost of Revenue | -23.05% | 4.45% | |||
| Gross Profit | -15.98% | 3.56% | |||
| SG&A Expenses | -4.26% | 6.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.46% | 3.38% | |||
| Operating Income | -49.03% | 8.67% | |||
| Income Before Tax | -65.23% | 178.31% | |||
| Income Tax Expenses | 0.00% | -68.33% | |||
| Earnings from Continuing Operations | -65.31% | 181.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -65.31% | 181.19% | |||
| EBIT | -49.03% | 8.67% | |||
| EBITDA | -30.99% | 5.37% | |||
| EPS Basic | -65.49% | 179.69% | |||
| Normalized Basic EPS | -51.89% | 10.17% | |||
| EPS Diluted | -65.25% | 177.78% | |||
| Normalized Diluted EPS | -51.89% | 10.17% | |||
| Average Basic Shares Outstanding | 0.56% | 0.51% | |||
| Average Diluted Shares Outstanding | 0.56% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||